|
Kalorama Information's 2025 IVD Atlas Tracks Global Growth Hotspots, Led by China and Emerging Markets
Tuesday, July 22, 2025
ARLINGTON, Va., July 14, 2025 /PRNewswire/ -- Kalorama Information, a leading authority in healthcare market intelligence, announces the release of its 30-Country IVD Market Atlas, 2025 (June Update)--an in-depth strategic resource offering the most comprehensive, country-specific analysis of the in vitro diagnostics (IVD) landscape across 30 key nations. With quarterly updates throughout the year, this data-rich report equips stakeholders with timely and actionable insights to navigate the fast-evolving global diagnostics market.
Timely Updates. Local Precision. Global Impact.
From the U.S., China, and Germany to Vietnam, Saudi Arabia, and South Africa, Kalorama's 30-Country IVD Market Atlas delivers granular market sizing, forecasts through 2029, and segmentation across 20+ critical IVD categories, including:
-- Molecular diagnostics (HIV, Hepatitis, Respiratory, HAI)
-- POC testing (Pregnancy, Glucose, Infectious Disease)
-- Immunoassays, Coagulation, Hematology, Histology
-- Microbiology and Core Lab/Critical Care
Unlike fragmented or outdated country reports, this atlas provides a single, continuously updated source for understanding demand, regulation, and competition across the globe -- ideal for strategic planning, product launches, market expansion, and M&A targeting.
Highlights in the 2025 June Update
-- China emerges as the fastest-growing IVD market of the 30 countries
tracked, with a projected CAGR nearing 9% through 2029--almost four
times the growth of slower-expanding markets like Egypt, Russia, and
Japan."China is one of the world's largest and fastest-growing IVD
markets, making it a key target for major vendors seeking to offset
slower growth in developed economies," said Daniel Granderson, Senior
Editor at Kalorama Information. "In 2024, glucose monitoring alone
accounted for over 20% of China's IVD value--and that momentum is just
beginning."
-- Countries such as Saudi Arabia, South Korea, Turkey, Vietnam, and the
UAE are all forecast to exceed 5% CAGR, driven by expanding healthcare
access, chronic disease burden, and tech adoption.
-- Russia's IVD market negatively impacted due to the withdrawal of foreign
businesses surrounding the Ukraine war.
-- The rise of AI, home testing, and personalized medicine continues to
reshape diagnostics delivery across nearly all regions.
Who Should Read This Report?
The 30-Country IVD Market Atlas is designed for:
-- Executive leadership and strategic planners at diagnostic and medtech
companies
-- Product and portfolio managers making localization or phase-out
decisions
-- Business development teams scouting M&A and partnership opportunities
-- Investors and private equity analysts assessing country-level growth
targets
-- Regulatory professionals tracking compliance landscapes and approval
trends
Get the Report Today
To access the full report or schedule a custom consultation, visit:
Purchase the 30-Country IVD Market Atlas, 2025
For custom research or enterprise access, contact:
Sheri Davie - Sales Director, Kalorama Information
sheri.davie@scienceandmedicinegroup.com
For media inquiries, contact:
Richa Singh - Vice President, Strategic & Insights Sales
richa.singh@scienceandmedicinegroup.com
About Kalorama Information
A division of Science and Medicine Group, Kalorama Information has been a trusted publisher of healthcare market research for over 25 years. Its analysts specialize in in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Kalorama is best known for its flagship title, The Worldwide Market for In Vitro Diagnostic Tests, and other authoritative benchmarks in the global medical technology space.
Kalorama works in close coordination with SMG brands including BioInformatics, SDi, and IMV, enabling deep insight across diagnostics, life sciences, and imaging markets.
Learn more at www.kaloramainformation.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/kalorama-informations-2025-ivd-atlas-tracks-global-growth-hotspots-led-by-china-and-emerging-markets-302501301.html
SOURCE Kalorama Information
|
|
|
|
|
|
 |
The New Identity Theft Crisis: AI Scams, Child Victims, and Credit Damage Are All Spiking | Jan 22, 2026
|
|
Fintech Startup BON Credit Secures $3.5 Million In Funding | Jan 22, 2026
|
|
PayDo Launches Unified Payment Infrastructure Suite for Digital Businesses | Jan 22, 2026
|
|
AllSci Launches Hypothesis Publishing: A Seamless Way to Share, Connect, and Advance Scientific Ideas | Jan 22, 2026
|
|
Nudge Security Unveils Industry's Most Comprehensive AI Security Governance Platform | Jan 22, 2026
|
|
Young Adult Sports Fiction Debut Featured in LibraryBub Selection for January | Jan 22, 2026
|
|
IoTeX Publishes MiCA-Compliant Whitepaper for IOTX, Enabling EU-Wide Alignment Under the New Regulatory Framework | Jan 22, 2026
|
|
Darwin CX Caps a Banner Year with AI Launch, Sold-Out Events, and Industry Book Launch | Jan 22, 2026
|
|
Canadian Fintech Tuhk Inc., Founded by Ethoca and NuData Security Veterans, Raises US$6 Million Seed Round Led by FINTOP, with Lloyds Banking Group and Capital One Ventures | Jan 22, 2026
|
|
TSX Venture Exchange Market Data Now Available Across Over 40 Blockchains via Chainlink | Jan 22, 2026
|
|
|
|
